UNION therapeutics announce results from the ADESOS Phase 2b study in atopic dermatitis confirming the potential of orismilast as a first-in-class safe and efficacious oral treatment
ADFN,
Orismilast Phase 2b results in atopic dermatitis (AD) presented today as a late-breaking oral presentation at the European…
UNION therapeutics announce results from the ADESOS Phase 2b study in atopic dermatitis confirming the potential of orismilast as a first-in-class safe and efficacious oral treatment
ProfitQuotes.com,
Orismilast Phase 2b results in atopic dermatitis (AD) presented today as a late-breaking oral presentation at the European…
UNION therapeutics announce results from the ADESOS Phase 2b study in atopic dermatitis confirming the potential of orismilast as a first-in-class safe and efficacious oral treatment
Yahoo! Finance USA,
Orismilast Phase results in atopic dermatitis (AD) presented today as a late-breaking oral presentation at the European Academy…